Responses
Abstracts Accepted for Publication
Public health, health services research and health economics
AB1086 The prevalence and the reactivation rates of hepatitis in patients who are taking an immunesupressive agent for treatment of a rheumatological disease
Compose a Response to This Article
Other responses
No responses have been published for this article.